Who Owns Anavex Life Sciences Stock?
NASDAQ: AVXLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 40.48%
- Held by insiders
- 1.71%
- Institutional holders
- 231
- Institutions 40.5%
- Insiders 1.7%
- Public and other 57.8%
Who owns Anavex Life Sciences stock?
Institutional investors own about 40.5% of Anavex Life Sciences's shares, spread across 231 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 1.71% of AVXL.
The largest institutional holders are Blackrock Inc. (8.69%), Vanguard Capital Management LLC (4.37%) and Two Sigma Investments, LP (3.29%). Together, the top 10 institutions control 26.2% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their AVXL positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AVXL
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 8.06M | 8.69% | +5.9% |
| Vanguard Capital Management LLC | 4.05M | 4.37% | +4.9% |
| Two Sigma Investments, LP | 3.05M | 3.29% | -6.2% |
| Geode Capital Management, LLC | 2.41M | 2.60% | +10.0% |
| State Street Corporation | 1.92M | 2.07% | -57.4% |
| Federated Hermes, Inc. | 1.07M | 1.16% | +101.4% |
| AQR Capital Management, LLC | 963.01K | 1.04% | +27.3% |
| Vanguard Portfolio Management LLC | 948.63K | 1.02% | +21.1% |
| Summit Financial, LLC | 909.43K | 0.98% | -3.3% |
| Goldman Sachs Group Inc | 890.63K | 0.96% | +10.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AVXL
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.93M | 3.16% |
| iShares Trust-iShares Russell 2000 ETF | 2.38M | 2.57% |
| Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund | 2.05M | 2.21% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.04M | 1.12% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.00M | 1.08% |
| iShares Trust-iShares Russell 2000 Value ETF | 729.59K | 0.79% |
| iShares Trust-iShares Biotechnology ETF | 667.44K | 0.72% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 450.28K | 0.49% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 440.21K | 0.47% |
| iShares Trust-iShares Micro-Cap ETF | 312.61K | 0.34% |
Frequently asked questions
Who is the largest shareholder of Anavex Life Sciences?
Blackrock Inc. is the largest institutional shareholder of AVXL, owning 8.69% of shares outstanding (8.06M shares) as of its latest 13F filing.
What percentage of Anavex Life Sciences is owned by institutions?
Institutions own about 40.5% of AVXL shares and 41.2% of the public float.
How much of Anavex Life Sciences do insiders own?
Insiders, such as officers and directors, own about 1.71% of AVXL shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.